LifeNet Health acquires Bioventus wound business for $85M cash

Bioventus divests wound business to LifeNet Health (MassDevice)
This sale is another sign of the tight financial times.
Unprofitable orthopedic companies are being force to sell off assets for cash. Accelus sold its REMI robot system to ATEC for $55M and Bioventus just sold its wound care business to LifeNet Health for $85M.

Bioventus (Nasdaq:BVS) announced today that it signed a definitive agreement to sell its wound business to LifeNet Health. Durham, North Carolina-based Bioventus’ sale includes its skin substitutes, TheraSkin and TheraGenesis. The transaction includes a total cash cons...